C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 5/46 (2006.01) A61P 11/06 (2006.01)
Patent
CA 2430577
This invention pertains to compounds which specifically inhibit the adenosine A1, A2A, and A3 receptors and the use of these compounds to treat a disease associated with A1, A2A, and A3 adenosine receptors in a subjects, comprising administering to the subject a therapeutically effective amount of the compounds.
L'invention concerne des composés qui inhibent de manière spécifique les récepteurs de l'adénosine A¿1?, A¿2A?, et A¿3? et l'utilisation de ces composés pour traiter une maladie associées aux récepteurs de l'adénosine A¿1?, A¿2A?, et A¿3? chez un sujet, par administration à ce dernier d'une quantité efficace sur le plan thérapeutique desdits composés.
Castelhano Arlindo L.
Mckibben Bryan
Witter David J.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Osi Pharmaceuticals Inc.
LandOfFree
Compounds specific to adenosine a1, a2a, and a3 receptor and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds specific to adenosine a1, a2a, and a3 receptor and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds specific to adenosine a1, a2a, and a3 receptor and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1912809